David E. Loudy

732 total citations
11 papers, 588 citations indexed

About

David E. Loudy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David E. Loudy has authored 11 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in David E. Loudy's work include Neonatal Respiratory Health Research (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). David E. Loudy is often cited by papers focused on Neonatal Respiratory Health Research (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). David E. Loudy collaborates with scholars based in United States, Canada and Germany. David E. Loudy's co-authors include Jeffrey A. Whitsett, Susan E. Wert, Joerg Huelsken, Michael L. Mucenski, Walter Birchmeier, Edward E. Morrisey, John T. Yarrington, John P. Gibson, James W. Newberne and Anne‐Karina T. Perl and has published in prestigious journals such as Journal of Biological Chemistry, Experimental Cell Research and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

David E. Loudy

11 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Loudy United States 9 321 252 145 89 70 11 588
Jonathan A. Cohn United States 8 333 1.0× 519 2.1× 306 2.1× 198 2.2× 63 0.9× 10 1.0k
Angela Robbiano Italy 9 265 0.8× 160 0.6× 41 0.3× 27 0.3× 39 0.6× 10 629
Xiu-Bao Chang United States 11 486 1.5× 617 2.4× 62 0.4× 165 1.9× 45 0.6× 15 951
P. Sardá France 19 327 1.0× 44 0.2× 83 0.6× 45 0.5× 241 3.4× 48 921
Caroline Schönfeld Germany 11 214 0.7× 48 0.2× 58 0.4× 57 0.6× 23 0.3× 14 584
Mark McCormack Ireland 11 207 0.6× 36 0.1× 23 0.2× 80 0.9× 54 0.8× 22 545
H. Kentrup Germany 13 551 1.7× 51 0.2× 122 0.8× 84 0.9× 18 0.3× 29 933
Surjit K. Datta United States 11 194 0.6× 28 0.1× 70 0.5× 110 1.2× 36 0.5× 23 536
Masaki Kanazawa Japan 14 336 1.0× 57 0.2× 88 0.6× 45 0.5× 24 0.3× 29 599

Countries citing papers authored by David E. Loudy

Since Specialization
Citations

This map shows the geographic impact of David E. Loudy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Loudy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Loudy more than expected).

Fields of papers citing papers by David E. Loudy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Loudy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Loudy. The network helps show where David E. Loudy may publish in the future.

Co-authorship network of co-authors of David E. Loudy

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Loudy. A scholar is included among the top collaborators of David E. Loudy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Loudy. David E. Loudy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Maeda, Yutaka, Thomas C. Hunter, David E. Loudy, et al.. (2006). PARP-2 Interacts with TTF-1 and Regulates Expression of Surfactant Protein-B. Journal of Biological Chemistry. 281(14). 9600–9606. 44 indexed citations
2.
Perl, Anne‐Karina T., et al.. (2005). Conditional Recombination Reveals Distinct Subsets of Epithelial Cells in Trachea, Bronchi, and Alveoli. American Journal of Respiratory Cell and Molecular Biology. 33(5). 455–462. 92 indexed citations
3.
Mucenski, Michael L., Susan E. Wert, David E. Loudy, et al.. (2003). β-Catenin Is Required for Specification of Proximal/Distal Cell Fate during Lung Morphogenesis. Journal of Biological Chemistry. 278(41). 40231–40238. 255 indexed citations
4.
Woessner, Richard, et al.. (1998). Microautoradiographic Quantitation of Vascular Endothelial Growth Factor mRNA Levels in Human Prostate Specimens Containing Normal and Neoplastic Epithelium. Experimental and Molecular Pathology. 65(1). 37–52. 10 indexed citations
5.
Wright, Paul S., et al.. (1997). Quantitation of Vascular Endothelial Growth Factor mRNA Levels in Human Breast Tumors and Metastatic Lymph Nodes. Experimental and Molecular Pathology. 64(1). 41–51. 5 indexed citations
6.
Wright, Paul S., John P.H. Th'ng, Xiaowen Guo, et al.. (1996). A Ribonucleotide Reductase Inhibitor, MDL 101,731, Induces Apoptosis and Elevates TRPM-2 mRNA Levels in Human Prostate Tumor Xenografts. Experimental Cell Research. 222(1). 54–60. 31 indexed citations
7.
Dillberger, John E., David E. Loudy, Rick R. Adler, & Jerome H. Gass. (1994). Hemobartonella-like Parasites in Cynomolgus Monkeys (Macaca fascicularis). Veterinary Pathology. 31(3). 301–307. 13 indexed citations
8.
Gibson, John P., et al.. (1990). Chronic Toxicity Studies with Vigabatrin, A GABA-Transaminase Inhibitor. Toxicologic Pathology. 18(2). 225–238. 107 indexed citations
9.
Yarrington, John T., et al.. (1990). Short-Term Studies of MDL 19,660-induced Canine Thrombocytopenia. Toxicologic Pathology. 18(4). 651–660. 1 indexed citations
10.
Yarrington, John T., et al.. (1983). Intestinal changes caused by dl-α-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase. Experimental and Molecular Pathology. 39(3). 300–316. 18 indexed citations
11.
Yarrington, John T., et al.. (1981). Effect of the hypolipidemic drug RMI 14,514 on hepatic ultrastructure of rats. Experimental and Molecular Pathology. 34(3). 307–322. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026